http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102775596-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G65-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-795 |
| filingDate | 2011-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102775596-B |
| titleOfInvention | D51-7059 and its production and use |
| abstract | The invention provides a kind of D51-7059 of energy inhibition tumor cell multidrug resistance, its preparation method and the purposes in inhibition tumor cell multidrug resistance.The molecular formula of described D51-7059 is: Pluronic-(S-S-PTX)n 2 , wherein, Pluronic is tensio-active agent pluronic, and its general structure is (HO-[CHn 2 cHn 2 o]n x -[CHn 2 cH (CHn 3 ) O]n y -[CHn 2 cHn 2 o]n x -H; X and y represents group number, and x is the integer of 2-100, and y is the integer of 30-70; PTX is antitumor drug paclitaxel; S-S-is disulfide linkage; Namely two molecule PTX are connected with a part Pluronic by disulfide linkage. |
| priorityDate | 2011-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.